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Abstract
Animal African trypanosomosis is a major threat to the economic development and human
health in sub-Saharan Africa. Trypanosoma congolense infections represent the major con-
straint in livestock production, with anemia as the major pathogenic lethal feature. The
mechanisms underlying anemia development are ill defined, which hampers the develop-
ment of an effective therapy. Here, the contribution of the erythropoieticand erythrophago-
cytic potential as well as of hemodilution to the development of T. congolense-induced
anemia were addressed in a mousemodel of low virulence relevant for bovine trypanoso-
mosis. We show that in infected mice, splenic extramedullary erythropoiesis could compen-
sate for the chronic low-grade type I inflammation-induced phagocytosis of senescent red
blood cells (RBCs) in spleen and liver myeloid cells, as well as for the impairedmaturation
of RBCs occurring in the bonemarrow and spleen. Rather, anemia resulted from hemodilu-
tion. Our data also suggest that the heme catabolism subsequent to sustained erythropha-
gocytosis resulted in iron accumulation in tissue and hyperbilirubinemia. Moreover,
hypoalbuminemia, potentially resulting from hemodilution and liver injury in infected mice,
impaired the elimination of toxic circulatingmolecules like bilirubin. Hemodilutional thrombo-
cytopenia also coincided with impaired coagulation. Combined, these effects could elicit
multiple organ failure and uncontrolled bleeding thus reduce the survival of infected mice.
MIF (macrophagemigrating inhibitory factor), a potential pathogenic molecule in African try-
panosomosis, was found herein to promote erythrophagocytosis, to block extramedullary
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erythropoiesisand RBCmaturation, and to trigger hemodilution. Hence, these data prompt
consideringMIF as a potential target for treatment of natural bovine trypanosomosis.
Author Summary
Bovine African trypanosomosis is a parasitic disease of veterinary importance that
adversely affects the public health and economic development of sub-Saharan Africa. Ane-
mia is a major cause of death associated with this disease. Yet, the mechanisms underlying
anemia development are not elucidated, which hampers the design of effective therapeutic
strategies.We show here that in a Trypanosoma congolense infectionmouse model rele-
vant for bovine trypanosomosis, red blood cells (RBCs) are generated in the spleen. This
compensates for the impaired maturation of RBCs occurring in the bone marrow, the nor-
mal site of RBC generation, and for the destruction of RBCs taking place in the liver and
the spleen. Instead, anemia results from an increase in blood volume (hemodilution). The
immune moleculeMacrophage Migration Inhibitory Factor (MIF) was found to drive
RBC destruction, to block RBCmaturation, as well as to trigger hemodilution. Iron accu-
mulation in tissue due to sustained RBC destruction and hemodilution causes tissue dam-
age, which culminates in the release of toxic molecules like bilirubin, in impaired
production of blood detoxifyingmolecules like albumin, and in defective coagulation.
Combined, these effects initiate multiple organ failure that can reduce the survival of
infectedmice. Given the unmet medical need for this parasite infection, our findings offer
promise for improved treatment protocols in the field.
Introduction
African trypanosomosis (AT) is a neglected tropical disease of medical and veterinary impor-
tance that adversely affects human health and welfare, as well as the economic development in
sub-Saharan Africa [1,2]. AT is caused by blood-bornehemoflagellated protozoan parasites
from the Trypanosoma genus that are transmitted by the hematophagous tsetse fly (Glossina
spp.) vector [3]. Trypanosoma-induced diseases in mammals include sleeping sickness in
humans or nagana in domestic livestock, with fatal consequences unless treated [4,5]. Given
that so far no effective vaccine is available, that certain trypanosome strains have become resis-
tant to curative and preventive treatments, and that eradication of tsetse flies remains impossi-
ble in most regions [1,6], strategies focusing at reducing AT-associated pathogenicity might be
an alternative approach to reduce the economic losses in cattle production.
In case of bovine trypanosomosis, the main difference between so-called trypano-suscepti-
ble and -tolerant animals relies in their capacity to control anemia development, the major
cause of death associated with the disease [7,8], and hereby to remain productive [9]. Differ-
ences in erythropoietic potential have been suggested as a contributing factor to anemia devel-
opment [8]. Yet, the mechanisms underlying this phenomenon remain poorly understood,
which hampers the design of effective therapeutic strategies. Given the similarities between the
anemic responses of cattle and C57Bl/6 mice upon trypanosome infection [8], the underlying
mechanisms were mainly scrutinized in murine models [10,11]. The data collectively suggest
that the pro-inflammatory type I immune response, involving TNF, IFN-γ and M1-type (clas-
sically activated) myeloid cells, contributes to pathogenicity in general and anemia in particu-
lar, and in combination with impaired B-cell functionality, results in reduced survival of the
MIF and Pathogenic Anemia
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mice [10,12,13]. Thus, identification of gene-products regulating pro-inflammatory signals
during the course of the diseasemight pave the way to develop novel intervention strategies. In
this context, we previously identifiedmacrophage migration inhibitory factor (MIF) as a
potential susceptibility marker for African trypanosomosis.This ubiquitously produced cyto-
kine is a prominent inducer of systemic inflammation in many inflammatory diseases [14,15]
that acts by recruiting and activating myeloid cells towards M1-type cells to the site of inflam-
mation [16,17], and by suppressing apoptosis of inflammatory cells [18]. We have shown using
a trypanosusceptiblemodel based on C57Bl/6 mice infectedwith T. brucei brucei, that MIF
contributes to tissue pathogenicity by sustaining throughout infection a persistent type I pro-
inflammatory chemokine (CXCL1, CCL2) and cytokine (IFN-γ, TNF, IL-6) response, and by
enhancing the recruitment of Ly6C+ monocytes and neutrophils (PMNs) in the liver with con-
comitant hepatomegaly [19]. Moreover, PMN- but not monocyte-derivedMIF was mainly
responsible for liver damage. In addition, MIF promotes the development of so-called anemia
of inflammation in trypanosusceptible mice by enhancing red blood cell (RBC) clearance from
the blood, and by triggering the storage of iron in liver myeloid cells that deprives iron from
erythropoiesis and impairs the generation of mature RBCs. However, despite reduced liver
injury and anemia levels in T. b. brucei-infectedMif-/-mice or mice treated with a neutralizing
anti-MIF antibody, the host survival time was not affected [19].
Compared to T. b. brucei, T. congolense infection in C57Bl/6 mice is considered a trypanoto-
lerant model more relevant for bovine trypanosomosis [20,21]. In contrast to T. b. brucei, T.
congolense causes a chronic infection (3–4 months versus 1 month), due to the capacity of T.
congolense-infectedmice to restrain the type I immune response and to switch to an IL-
10-mediated tissue protective anti-inflammatory response [21,22]. This model could thus
allow a thorough analysis of the mechanisms underlying anemia development in an immune
environment different from that of anemia of inflammation. Here, we evaluated the role of
MIF in T. congolense infection-associatedanemia development, by focusing on the modulation
of the erythropoietic and erythrophagocyticpotential in tissues including the bone marrow,
the spleen and the liver. Additionally, the contribution of hemodilution to anemia was
addressed.
Results
1. MIF deficiency correlateswith prolonged survival and reduced tissue
pathogenicity during T. congolense infection
The systemic production of MIF increased progressively during the course of T. congolense
infection (S1 Fig). Hence, the potential role of MIF in the outcome of i.p. infectionwas evalu-
ated by comparing wild type (WT) and MIF-deficient (Mif-/-) C57Bl/6 mice. Although parasi-
temia development was similar inWT andMif-/- mice, a prolongation of median survival time
occurred inMif-/- mice (Fig 1A and 1B). Similar observationswere obtained using a natural
route, tsetse fly-mediated infectionmodel (S2A and S2B Fig). Considering the similar capacity
of WT andMif-/-mice to control parasite growth, the increased survival ofMif-/-mice could
result from lower tissue pathogenicity [23,24]. In agreement, as compared toWTmice,Mif-/-
mice exhibited reduced serumAST (alanine aminotransferase, reflecting systemic tissue injury)
and ALT (aspartate aminotransferase, reflecting liver injury) levels (Fig 1C and 1D), as well as
reduced hepato- and splenomegaly that coincidedwith a lower increase in the number of white
blood cells (WBC) in the liver and the spleen ofMif-/-mice (Figs 1E and 1F and S3). No WBC
accumulation was observed in the bonemarrow of infectedWT andMif-/-mice (Fig 1F).
The differences in pathogenicity betweenWT andMif-/- infectedmice were clearly estab-
lished from 3 months post infection (p.i.) (Figs 1C–1F and S3), hence we focused at this time
MIF and Pathogenic Anemia
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Fig 1. MIF deficiencyconfers partial protectionand reduces hepatosplenomegaly andwhite blood cell accumulation
duringT. congolense infection. (A)Parasitemia, (B) survival, serum (C)AST and (D)ALT levels in infected mice. During the
course of infection, (E) liver and spleen weight as well as (F) liver, spleen and bonemarrowwhite blood cell (WBC) numbers.
For bonemarrowWBCs, only data from 3 months p.i. are shown.Wild type (WT, black symbol);Mif-/- (white symbol) mice.
Results are representative of 2 (E) or 3 independent experiments and presentedas mean (A, C, D, E, F) or median (B) of 3–5
individualmice ± SEM. *: p0.05, **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g001
MIF and Pathogenic Anemia
PLOS Pathogens | DOI:10.1371/journal.ppat.1005862 September 15, 2016 4 / 26
point. At 3 months p.i., MIF secretionwas enhanced in the liver, spleen and bonemarrow of
infectedWTmice (Fig 2), mirroring the increasedMIF level measured in the blood. In agree-
ment with the reduced tissue injury in infectedMif-/-mice, the levels of neutrophil (CXCL1)
and monocyte (CCL2) chemoattractants, as well as of pro-inflammatory cytokines docu-
mented to contribute to T. congolense-induced tissue destruction (TNF, IL-6, IFN-γ) [25,26],
were increased to a lesser degree in the liver, spleen, bone marrow and blood ofMif-/- thanWT
mice (Fig 2A–2D). This was also true for IL-12p70 in the blood (Fig 2D) [27]. However, the
systemic and tissue levels of IL-10, which increases upon T. congolense infection and is crucial
to limit tissue destruction [28], did not differ betweenWT andMif-/-mice (Fig 2).
In addition to differences in pro-inflammatory cytokine production, the decreased tissue
pathogenicity and increased survival ofMif-/-mice also could be due to a superior ability of the
Mif-/-mice to mount a parasite-specific antibody response [13]. As shown in Figs 3A and S4,
similar serum levels of parasite-specific IgG antibodies were recorded inWT andMif-/-mice
until 1.5 months p.i.; thereafter and from 3months p.i., the IgG levels declined inWTmice while
they remained elevated inMif-/-mice. The drop in IgG levels in infectedWTmice did not corre-
late with a decrease in the number of total (B220+) or germinal center (GL-7+Fas+B220+) splenic
B-cells (Figs 3B and 3C, S5A and S5B), but could be due to an increase in B-cell apoptosis (Fig
3D). The increased IgG levels observed in infectedMif-/- mice as compared toWTmice was asso-
ciated with an increased number of total and germinal center B-cells as well as with lower B-cell
apoptosis (Fig 4A–4D).
Fig 2. MIF contributes to pathogenic chemokineand cytokineproductionduringT. congolense infection. At 3 months p.i., ex-vivo protein
levels of MIF, CXCL1, CCL2, TNF, IL-6, IFN-γ and IL-10 in (A-C) supernatant from the liver, spleen, and bonemarrow cell cultures, and (D) in the
blood. IL-12p70 levels in blood are shown for WT (black bar) andMif-/- (open bar) mice. Protein levels in non-infectedmice (dashed line) were
similar in both mouse strains. (N.D.: not detectable). Results are representative of 3 independent experiments and presentedas mean of 3
individualmice ± SEM. *: p0.05, **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g002
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Collectively, in T. congolense-infectedmice, the absence of MIF results in a reduced pro-
inflammatory immune response, which in turn could contribute to a lower hepato-splenomeg-
aly and an enhanced B-cell response that collectively could enhance the survival time.
2. MIF deficiency correlateswith reduced anemia during T. congolense
infection
Anemia is the prominent pathogenic feature of a natural T. congolense infection, which is
mediated by hematopoietic cells, but not by T lymphocytes or antibodies [10,29]. SinceMIF (i)
contributes to the accumulation of WBC (including phagocytes; Fig 1F) in tissues that are
potentially involved in erythrophagocytosis and extramedullary erythropoiesis, and (ii) stimu-
lates the production of the erythroid lineage development-blocking cytokine IL-6 [30] in the
two main erythropoietic tissues (bonemarrow, spleen; Fig 2B and 2C), we investigated MIF’s
role in anemia development during T. congolense infection.
Anemia is characterized by two distinct phases: (i) a rapid decline in RBC levels followed by
partial recovery during the early phase of infection and (ii) a more progressive decline in RBC
levels during the chronic phase of infection (Fig 4A). During the early phase of infection (i.e.
day 5–10 p.i.), the RBC percentages initially dropped to about 50% of non-infectedmice in
bothWT andMif-/- mice (Fig 4A). Between day 10–14 p.i., a partial recovery that reaches
about 75% of the RBC level in non-infectedmice occurred inWTmice, while inMif-/- mice
Fig 3. MIF deficiency preserves parasite-specific IgG responses, maintainsgerminal center formation and
preventsB-cell apoptosisduringT. congolense infection. (A)Parasite-specific blood IgG level (1/500 dilution)
inWT (black bar) andMif-/- (open bar) mice at 1.5, 3 and 4 months p.i.. At 3 months p.i. (B) absolute numbers of
B220+MHC-II+ B-cells and (C) of germinal GL-7+Fas+ B-cells and (D) percentageof Annexin-V+ B220+ cells in the
spleen of WT (black bar) andMif-/- (open bar) mice were determined using the gating strategy described in S5A and
S5B Fig. Results are representative of 2 independent experiments and presented as mean of 3 individual
mice ± SEM. *: p0.05, **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g003
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PLOS Pathogens | DOI:10.1371/journal.ppat.1005862 September 15, 2016 6 / 26
this recovery reached about 95% (Fig 4A). Subsequently, during the chronic phase of infection,
the RBC levels declined progressively and remained significantly lower inWT thanMif-/- mice.
Mif-/- mice also exhibited reduced anemia in a natural tsetse fly-mediated infection (S2C Fig).
The serumhemoglobin and iron levels were reduced inWTmice as compared to non-infected
animals during the course of infection (Fig 4B and 4C). In infectedMif-/- mice, these reductions
were less pronounced when compared to infectedWTmice. In both groups of mice, the serum
hemoglobin and iron levels reached nadir levels at 3 months p.i., the time point when the dif-
ferences in tissue pathogenicity were established (Figs 1C and 1D and 4A).
Collectively, during the chronic stage of T. congolense infection,MIF partially impaired recov-
ery from early stage anemia and contributed to the decline in serumhemoglobin and iron levels.
3. Mif-/- mice recover from dyserythropoiesisduring T. congolense
infection
Typically, in response to chronic anemia, splenomegaly and increased blood reticulocyte con-
tent are indicative of inefficient erythropoiesis in the bonemarrow and extramedullary
Fig 4. MIF deficiencypartially reduces anemia duringT. congolense infection. (A)Anemia development in infectedWT (closed symbol) andMif-/-
(open symbol)mice. Number of RBCs in non-infectedmice was set as 100%. At 1.5, 3 and 4 months p.i., (B) serumhemoglobin levels, (C) serum iron
levels, and (D) numbers of splenic white blood cells (WBC, black bar) and RBCs (white bar) were determined. Results are representative of 2 independent
experiments and presented as mean of 3 individualmice ± SEM. **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g004
MIF and Pathogenic Anemia
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erythropoiesis in the spleen [31]. Compared to non-infectedmice, the numbers of splenic
Ter119+ RBCs increasedmore prominently in T. congolense-infectedWT thanMif-/- mice
from 3 months p.i. (Fig 4D). Remarkably, the largest increase in cell number in the spleens of
infectedmice was found in the RBC and not theWBC compartment (Fig 4D), showing the
expansion of the erythroid compartment as a main cause for T. congolense-associated
splenomegaly.
The relative abundance of Ter119+CD71+ reticulocytes and mature Ter119+CD71- RBCs
(identified as described in S6A Fig) was quantified in the blood of WT andMif-/- mice at 3
months p.i., which corresponds with a time point whenmaximal cell numbers, level of hepato-
splenomegaly and tissue pathogenicity were reached in both groups of mice (Figs 1C–1F and
S3). The concentration of reticulocytes increased in the blood of infectedWTmice when com-
pared to non-infected animals, and this increase was less pronounced inMif-/- mice (Fig 5A).
Concomitantly, the reduction in the concentration of mature RBCs was more pronounced in
the blood of WT thanMif-/- mice.Within the erythropoietic tissues of infectedWTmice, retic-
ulocyte and mature RBC accumulation was not affected in the bone marrow, but was dramati-
cally increased in the spleen (Fig 5B and 5C), suggesting extramedullary erythropoiesis.A
comparison of infectedWT andMif-/-mice revealed a detrimental contribution of MIF to
mature RBC accumulation in the bonemarrow, and to reticulocyte accumulation in the spleen
(Fig 5B and 5C).
Next, we assessed the stage at which erythropoiesis could be affected (from nucleated eryth-
roblasts (I) until enucleated erythrocytes (VI)), by gating for Ter119+ RBCs in a CD44 versus
FSC-A plot [32] (S6B Fig). In the bonemarrow of infectedWTmice, a blockade in the two last
steps of RBC differentiation resulted in decreased percentage (S6C Fig) and numbers (Fig 5D)
of nucleated reticulocytes (stage V) and enucleated reticulocyte/erythrocyte (stage VI) cells. In
the spleen, infectedWTmice exhibited increased accumulation of the RBC differentiation
stage III polychromatic erythroblasts to stage VI mature RBCs (Fig 5E), confirming extrame-
dullary erythropoiesis in this organ. The erythropoiesis efficacy in the bone marrow and the
spleen was improved in infectedMif-/- as compared toWTmice. Indeed,Mif-/- mice exhibited
a more efficient RBCmaturation mainly during the transition from orthochromatic erythro-
blasts and nucleated reticulocytes (stage IV and V) to the last step of differentiation i.e. enucle-
ation of erythrocytes (stage VI, Fig 5D and 5E). Of note, the gene expression levels of Vcam1
(Vascular cell adhesionmolecule-1) andMaea (EMP: erythroblast-macrophage protein), two
molecules crucial for erythroblast—macrophage interaction in the terminal stage of erythro-
poiesis, i.e. during the erythroblast enucleation [33,34], were higher inMif-/- than inWTmice
(Fig 5F), suggesting a negative effect of MIF on the reticulocyte terminal maturation.
Collectively, these data indicated that mice exhibited reticulocytosisduring the chronic
stage of T. congolense infection, which was likely due to an increased production of RBCs,
mainly in the spleen, to overcome the chronic loss of mature RBCs observed in the blood.
Moreover, RBCs were impaired in their terminal stages of maturation both in the bone marrow
and spleen of infectedmice. Finally, MIF contributed to the reticulocytosis and to the
impairment of the terminal differentiation of RBCs from the orthochromatic erythroblast to
the enucleated reticulocyte/erythrocytestage.
4. Mif-/- mice exhibit reduced erythrophagocytosis,heme catabolismand
tissue iron accumulation during T. congolense infection
The percentage of bloodAnnexin-V+ RBCs increased in T. congolense-infectedWTmice, and
this increase was lower inMif-/- than inWTmice (Fig 6A). Phosphatidylserine exposure,
which forms the basis of the Annexin-V staining assay, is an “eat-me” signal observedduring
MIF and Pathogenic Anemia
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Fig 5. MIF contributes to dyserythropoiesis duringT. congolense infection. At 3 months p.i., (A-C) numbers of
matureRBCs (erythrocytes, Ery.) and immatureRBCs (reticulocytes, Ret.) defined as described in S6A Fig in (A) blood,
(B) bonemarrow and (C) spleen of WT andMif-/-mice. WT (black bar),Mif-/- (open bar) and non-infected (grey bar) mice.
Results are representative of 3 independent experiments and shown as mean of 3 individualmice ± SEM. (D, E)Numbers
of the different erythroidpopulations (defined as described in S6B Fig) in (D) bonemarrow and (E) spleen. (F)Gene
expression levels of Vcam1 andMaea in total spleen fromWT (black bar) andMif−/− (white bar) mice at 3 months p.i.
Gene expression levels were normalizedusing S12 and expressed relatively to expression levels in non-infected mice.
Results are representative of 2 independent experiments and presented as mean of 3–5 individual mice ± SEM. *:
p0.05, **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g005
MIF and Pathogenic Anemia
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apoptosis of senescent cells. Thus, we investigated whether an increased RBC elimination
through phagocytosis in the liver and the spleen contributed to anemia in T. congolense-
infectedmice. An assay consisting of i.v. injection of pHrodo-labeled RBCs in infectedWT or
Mif-/- mice followed by analysis of the appearance of a fluorescent signal in phagocytes from
the liver and the spleen that have engulfed labeled RBCs [35], was used. In infectedWTmice,
PMNs, monocytes and macrophages (gated as in S7A Fig) exhibited RBC phagocytic activity.
This activity was more pronounced and MIF-dependent for PMNs in the liver and for mono-
cytes and macrophages in the spleen (Fig 6B and 6C). In parallel, a higher number of phago-
cytic PMNs, monocytes and macrophages was observed in the liver of infectedWTmice when
compared toMif-/-mice (Fig 6B and 6C). The same held true for macrophages in the spleen.
Together, these data suggest that the reduced anemia in T. congolense-infectedMif-/-mice is a
combined effect of a reduced apoptosis/senescence of RBCs, a reduced number of phagocytic
cells and a reduced phagocytic capacity of these cells.
Fig 6. MIF contributes to erythrophagocytosis duringT. congolense infection. (A)Representative Annexin-V gating
strategy and percentageof Annexin-V+ RBCs in blood of WT (black bar) andMif-/- (open bar) mice. (B, C left panel)At 3
months p.i., 109 pHrodo labelled RBCs isolated from non-infectedWTmice were injected i.v. in WT (black bar) orMif-/-
(open bar) mice. 18 h later, mice were sacrificed, liver (B) and spleen (C)myeloid phagocytic cells (MPC), namely
CD11b+Ly6CintLy6G+ PMNs, CD11b+Ly6ChighLy6G- monocytes and CD11b+Ly6C-Ly6G-F4/80+ macrophages (identified
as described in S7A Fig) were tested for delta median fluorescent intensity (MFI) of the intracellular pHrodo signal
determinedby subtracting the PE signal of cells frommice receiving unlabeledRBCs from the PE signal of cells frommice
receiving pHrodo-labeledRBCs. (B, C right panel)Numbers of MPC in the (B) liver and (C) spleen of WT (black bar) or
Mif-/- (open bar) mice. Results are representative of 2 independent experiments and presented as mean of 3 individual
mice ± SEM. *: p<0.05; **: p<0.01.
doi:10.1371/journal.ppat.1005862.g006
MIF and Pathogenic Anemia
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Erythrophagocytosis results in the release of hemoglobinwithin liver and spleen phagocytes,
where the heme is catabolized to iron, carbonmonoxide and bilirubin. The latter is then
released in the circulation and coupled to albumin to be transported to hepatocytes [36].
Accordingly, histological analyses revealed iron accumulationmainly in the splenic tissue of
infectedWTmice (Fig 7A and 7B). Furthermore, the observed erythrophagocytosis in T. con-
golense-infectedWTmice coincidedwith a progressive increase in total bilirubin and decrease
in albumin serum levels (Fig 7C and 7D). The decreased anemia and erythrophagocytosis
observed in infectedMif-/-mice correlated with lower intracellular iron retention, lower biliru-
binemia and higher albuminemia as compared toWTmice (Fig 7A–7D).
Fig 7. MIF contributes to heme catabolism and tissue iron accumulation duringT. congolense
infection. At 3 months p.i., (A) iron depositionwas quantified on spleen and liver sections of WT (black bar)
andMif-/- (open bar) mice and expressed as % of stained area analyzed in a region of interest. Non-infected
(dashed line) mice. (B)Representative Perl’s Prussian staining on spleen sections. (C, D)At 1.5, 3 and 4
months p.i., serum (C) total bilirubin and (D) albumin levels inWT andMif-/-mice. Values represent
mean ± SEM of 5 mice per group. One representative of 2 independent experiments is shown. **: p<0.01; ***:
p<0.005.
doi:10.1371/journal.ppat.1005862.g007
MIF and Pathogenic Anemia
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5. MIF contributes to hemodilution in T. congolense-infectedmice
Hemodilution can also contribute to anemia [37]. Moreover, the hypoalbuminemia observed
in T. congolense-infectedmice may also reflect hemodilution. APC-labelled hydroxyethyl
starch (HES) is used to monitor hemodilution and is not affected by differences in RBC num-
bers. Hence, HES was injected i.v. in WT andMif-/-mice at different time points post T. congo-
lense infection. After 5–10 minutes, the bloodwas collected and the blood volume and
concentration of HES were evaluated. As compared to non-infectedmice, the bloodHES con-
centration dropped in infectedWTmice while the volume of the blood collected increased,
whereby there was about a 3-fold change from 3 months p.i. (Fig 8A and 8B). These data sug-
gest that hemodilutionwas occurring in T. congolense-infectedmice during the later stage of
infection. In agreement with observations in T. congolense-infected cattle [38], the packed cell
volume (PCV) of the collected bloodwas reduced inWTmice as compared to non-infected
animals (Fig 8C). However, when taking into account the blood volume in the whole animal, it
appeared that the total PCV, i.e. the total amount of RBCs, was not affected by the infection
while the plasma volume was increased (Fig 8D). When compared to infectedWTmice, the
blood and plasma volume were lower, and the HES concentration and total PCV were higher
in infectedMif-/-mice (Fig 8A–8D). Together, these data indicated that anemia resulted from
MIF-dependent hemodilution and not from lower production of RBCs in T. congolense-
infectedmice.
Hemodilution can also give rise to a reduction in platelet concentration, which in turn con-
tributes to inefficient blood coagulation. As shown in Fig 8E, the concentration of FSClo/SSClo
CD41+ platelets (gated as in S7B Fig) declined in T. congolense-infectedWTmice and to a
lesser extent also inMif-/-mice. However, when taking into consideration the total blood vol-
ume, the number of platelets per animals was not affected by the infection (Fig 8F). Further-
more, the platelet dilution was associated with a drastic increase in clotting time in infected
WTmice. Indeed, while the clotting time of non-infectedmice was about 2 minutes,>70% of
the infectedWTmice continued to bleed 15 minutes after the tail cut (time at which the
wound was sealed following ethical guideline to avoid otherwise lethal hemorrhage) (Fig 8G).
The coagulation time in infectedMif-/-mice was higher than in non-infectedmice but
remained lower than in infectedWTmice, with all mice coagulating in about 10 minutes.
Collectively, these data suggest that MIF contributed to hemodilution that coincidedwith
decreased blood platelet concentration. Combined, these effects can result in inefficient coagu-
lation during T. congolense infection.
6. MIF treatment recapitulates anemia by impairing terminal erythroid
differentiation and by inducing hemodilution in T. congolense-infected
Mif-/- mice
To further assess whetherMIF triggered hemodilutional anemia,Mif-/-mice at 3 months p.i.
were treated with recombinant mouseMIF (rMIF) every second day for 1 week and tested for
anemia-associated parameters. rMIF-treatedMif-/-mice exhibited a more severe anemia than
untreatedMif-/-mice, reaching a percentage of RBC levels close to that of infectedWTmice
(Fig 9A). Moreover, the number of erythrocytes and reticulocytes—albeit to a non-significant
extent, decreased in the blood of rMIF-treatedMif-/-mice (Fig 9B). This effect coincidedwith a
drop in the terminal stage VI of erythroid development in the spleen, which paralleled the
results of WTmice (Fig 9C), thereby strengthening the notion that MIF affected the reticulo-
cyte enucleation process. In addition, rMIF treatment increased the level of annexin-V+
apoptotic RBCs (Fig 9D). Finally, infected rMIF-treatedMif-/-mice exhibited an increased
plasma volume recovered from the whole animal, increased splenomegaly, and a decreased
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Fig 8. MIF contributes to hemodilutionduringT. congolense infection. At 1.5, 3 and 4 months p.i., 10 μg APC-conjugated
hydroxyethyl starch (HES) were injected i.v. in WT (black bar) orMif-/- (open bar) mice. Mice were exsanguinated 5–10
minutes later via cardiac puncture and tested for (A)HES concentration, (B) the total blood volume collected and (C)Pack cell
MIF and Pathogenic Anemia
PLOS Pathogens | DOI:10.1371/journal.ppat.1005862 September 15, 2016 13 / 26
concentration but not number of platelets (Fig 9E–9H). Collectively, these data showed that
rMIF treatment in T. congolense-infectedMif-/-mice could partially recapitulate the pathogenic
features associated with anemia and hemodilution development in infectedWTmice. These
rMIF treatment data further support the conclusion that MIF exerted negative effects on ane-
mia and hemodilution development during the later stage of T. congolense infection.
Discussion
We have recently reported that MIF, an upstream regulator of the inflammatory response, con-
tributed to anemia in trypanosusceptibleT. b. brucei-infectedC57Bl/6 mice [19]. As compared
to T. b. brucei-infectedmice that are locked in a type I inflammatory immune response, T. con-
golense-infectedC57Bl/6 mice are trypanotolerant due to their ability to restrict the type I
driven immune response and to mount a tissue-protective IL-10-mediated immune response
in the chronic phase of infection [10,26]. Based on the observation that MIF was produced in
the chronic phase of T. congolense infection, we hypothesized that this less virulent model of
African trypanosomosis could allow a refined analysis of the MIF-dependent pathogenic mech-
anisms at play during infection-induced tissue damage and anemia.
As in trypanosusceptiblemice, in the absence of MIF, the systemic and tissue-restrictedpro-
duction of pathogenic chemokines (CXCL1, CCL2) and cytokines (IFN-γ, TNF, IL-6, IL-
12p70) was impaired during the chronic stage of T. congolense infection.MIF deficiency also
limited hepato-splenomegaly and tissue destruction, including anemia. In both T. b. brucei-
and T. congolense-infectedmice, the reduced anemia inMif-/-mice coincided with a partial
recovery of serumhemoglobin and iron levels. The higher iron bioavailability partially restored
erythropoiesis,which was reflected by a decreased concentration of reticulocytes and increased
concentration of RBCs in the blood and the spleen of infectedMif-/-mice. The absence of MIF
also improved the terminal stage of erythroid development, i.e. the differentiation from nucle-
ated reticulocytes to enucleated RBCs. The latter effect can result from the reduced circulating
IL-6 levels in infectedMif-/-mice [30]. The reduced anemia observed in T. b. brucei- and T.
congolense-infectedMif-/- mice also could result in part from the better RBC recovery during
the early stage of infection (up to 15 days p.i.), which in turn could require a lower erythropoi-
etic demand during the latter stages of infection.
In cattle, anemia development can result from the extravascular destruction of RBCs due to
massive erythrophagocytosis by activated macrophages in the spleen and the liver [39]. We
found that enhanced erythrophagocytosis indeed occurred in both the spleen and the liver of
T. congolense-infectedWTmice. This phenomenon was less pronounced inMif-/- mice despite
their better IgG response, and likely due to the reduced number of phagocytic hepatic macro-
phages, Ly6C+ monocytes and PMNs, and of splenic macrophages. Because of the increased
erythrophagocytic activity throughout T. congolense infection, a compensatory demand for
increased production of RBCs was evidenced in the spleen but not in the bonemarrow. This
extramedullary erythropoiesis led to a massive generation and accumulation of reticulocytes
and mature RBCs that could account for the splenomegaly observed in infectedmice. In the
absence of MIF, an increasedmaturation of reticulocytes to mature RBCs occurred and coin-
cided with reduced splenomegaly and anemia. One week of rMIF treatment in infectedMif-/-
volume (PCV). (D) Total plasma (white bar) and PCV (black bar) volumes calculated based on the total blood (B) and the%
PCV (C). (E)Concentration of CD41+ platelets (gated as described in S7B Fig) was determinedat 3 months p.i. (F) Total
number of platelets in the total blood volume. (G)Bleeding time of non-infected (N) and 3 months infected (I) mice. For ethical
reasons the bleeding of WTmice was stopped by sealing the wound after 15 minutes. Results are representative of 2
independent experiments and presented as mean of 7 individual mice ± SEM. **: p<0.01; ***: p<0.005.
doi:10.1371/journal.ppat.1005862.g008
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Fig 9. rMIF treatment in T. congolense-infected MIF-/- mice recapitulates anemia and hemodilution development. At 3
months p.i.,Mif-/- mice received 200 ng rMIF every second day for 1 week. (A)Percentage of RBCs in blood, whereby the
number of RBCs in non-infectedmice was set as 100%; (B)Numbers of blood mature (erythrocytes, Ery.) and immature
(reticulocytes, Ret.) RBCs defined as described in S6A Fig; (C)Percentage of the different erythroidpopulations defined as
described in S6B Fig in the spleen; (D)Percentage of blood Annexin-V+ RBCs gated as in Fig 6A; (E) Total plasma (white bar)
and PCV (black bar) volumes calculated based on the total blood volume and the% PCV; (F)Spleen and liver weights; (G, H)
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mice in turn recapitulated anemia development, including splenomegaly, increased apoptosis/
senescence of RBCs and impaired maturation of reticulocytes.
Our accumulated evidence argues for hemodilution, and not erythrophagocytosis, as the
main contributor to the chronic anemia developing in T. congolense-infectedmice in a MIF-
dependent manner. Despite a study showing no increase in the blood volume in T. congolense-
infected calves [40], others found a marked hypervolemia in T. congolense-infected sheep and
calves [41–45]. In line with the latter observations, the blood and plasma volume was aug-
mented in infectedWTmice. However, the total number of RBCs in the blood of infectedWT
mice, calculated on the basis of the blood volume and the PCV, did not differ from that of non-
infectedmice. These data suggested that hypervolemic hemodilution developed in infected
mice. They also suggested that, in infectedWTmice, the increased erythropoiesis and matura-
tion of RBCs in the spleen could compensate for both the impaired maturation of RBCs in the
bonemarrow and the increased clearance of RBCs through erythrophagocytosis in the liver
and the spleen. Remarkably, in anemic T. b. brucei-infectedWTmice, the blood and plasma
volumes were not affected and the PCV decreased (S8 Fig), in line with observation in T. b. bru-
cei-infected calves [46]. Collectively, these data support the view that a predominantly inflam-
matory anemia, i.e. anemia of inflammation, develops in a type I immune environment in T. b.
brucei-infectedmice [10,47], while a predominantly hemodilutional anemia occurs in a type II
environment in T. congolense-infectedmice. rMIF treatment in infectedMif-/-mice phenocop-
ied the hemodilution development, confirming a MIF-dependent mechanism in infectedWT
mice. Hemodilution in rMIF-treatedMif-/-mice however did not reach the level observed in
WTmice. Although this result could argue for the occurrence of MIF-independentmecha-
nisms of hemodilution, we cannot exclude the possibility that rMIF treatment for a period lon-
ger than one weekmay be necessary.
Hemodilution could also account for the reduced concentration of platelets in the circula-
tion of T. congolense-infectedWTmice. This hemodilutional thrombocytopenia concurred
with a delayed blot clotting time in infectedmice that could lead to lethal haemorrhage when
the tail cut for blood sampling was not sealed. Of note, thrombocytopeniawas reported to
occur in T. congolense-infected cattle and sheep [41,48]. Whether hemodilution of the clotting
factors also accounts for the inefficient coagulation in infected animals deserves further
investigation.
Despite similarly decreasing tissue pathogenicity, a difference in the pathogenic role of MIF
between trypanosusceptible and trypanotolerant mice nevertheless was observed. In T. b. bru-
cei-infectedmice, MIF deficiency resulted in increased production of IL-10, the main anti-
pathogenic cytokine in experimental African trypanosomosis, but did not affect the survival
time of the infected hosts [19]. In T. congolense-infectedmice, the absence of MIF had no effect
on IL-10 production but resulted in prolonged survival time. AlthoughMIF-independent
mechanisms could determine the survival of T. b. brucei-infectedmice, we could not exclude
that these mice are not sufficiently responsive to IL-10 [49,50]. Alternatively, the virulence of
T. b. brucei due to its tissue-invading capacity could be higher than that of T. congolense, which
remains strictly in the blood vessels [51]. It is postulated that T. b. brucei- and T. congolense-
infectedmice die from inflammation-mediatedmultiple organ failure [12], but the cause of
death remains unclear and may differ between the two parasite species. In this respect, a refined
mechanism for the death of T. congolense-infectedWTmice could be envisaged based on the
Concentration and number of CD41+ platelets gated as described in S7B Fig in total blood volume were determined in rMIF-
treatedMif-/- mice (grey bar) as well as inMif-/- (open bar) andWT (black bar) mice. Results are representative of 2
independent experiments and presented as mean of 3–5 individualmice ± SEM. *: p0.05, **: p0.01, ***: p0.001.
doi:10.1371/journal.ppat.1005862.g009
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data reported herein. Our results support the interpretation that in these animals, the continual
and month-lasting low-grade inflammatory response drives erythrophagocytosis and that the
ensuing catabolism of hemoglobin resulted in iron accumulationmainly in the spleen, followed
by the enhanced release of bilirubin in the blood circulation. Importantly, hyperbilirubinemia
could favour the externalisation of phosphatidylserine on RBCs observedherein and thus fur-
ther contribute to erythrophagocytosis or eryptosis during T. congolense infection [36,52]. The
hyperbilirubinemia and the hypoalbuminemia—with the latter resulting most likely from the
hemodilution and liver damage in infectedmice, could contribute to a greater degree of sys-
temic tissue destruction, including not only the hepatic tissue but also the heart and the brain
[53,54]. The severe hemodilutional anemia could also reduce cerebral oxygen delivery and fur-
ther promote cerebral damage [55,56], although T. congolense is not a blood brain barrier pene-
trating parasite. Combined, the hyperbilirubinemia, hypoalbuminemia, and hemodilution
could thus contribute importantly to the increasedmortality of T. congolense-infectedWT
mice. Thrombocytopenia and delayed coagulation, as correlates of hemodilution, could also
negatively impact the survival of infectedWTmice. MIF deficiencypartially alleviated iron
accumulation in tissues, hyperbilirubinemia, hypoalbuminemia and defective coagulation,
most likely becauseT. congolense-infectedMif-/-mice exhibited reduced erythrophagocytosis
combined with reduced hemodilution and liver injury. Each of these effectsmay be contribu-
tory to the enhanced survival ofMif-/-mice. Of course, our data do not exclude the reduced
inflammatory cytokine response and the better parasite-specific antibody response, both vital
for the control of African trypanosomosis [13,28,57], as reasons for the enhanced survival of T.
congolense-infectedMif-/-mice.
Collectively, our results suggest that during the chronic phase of T. congolense infection,
anemia did not result from the impaired production of mature RBCs.MIF-induced splenic
extramedullary erythropoiesis could compensate for the impaired differentiation of erythro-
blasts in the bone marrow and for the enhanced erythrophagocytosis in the liver and the spleen
(Fig 10). In contrast, anemia induced by T. congolensemainly occurred throughMIF-depen-
dent hemodilution. The heme catabolism ensuing erythrophagocytosis could lead to iron accu-
mulation in tissue and to hyperbilirubinemia. Hypoalbuminemia resulting from hemodilution
in infectedmice impaired the elimination of toxic circulatingmolecules, including bilirubin.
Hemodilution with thrombocytopenia as a consequence could also account for impaired coag-
ulation in infectedmice. Combined, these effects could triggermultiple organ failure and
uncontrolled bleeding hereby reducing the survival time of infectedmice. Together, this study
suggests that interfering with MIF signaling could represent an approach to limit inflamma-
tion-associated anemia complications during natural T. congolense trypanosomosis.Given that
polymorphisms in the humanMIF gene contribute to differences in susceptibility in several
inflammatory diseases [58,59], it could be interesting to assess whether differences between try-
panosusceptible and trypanotolerant cattle associates with genetically-predetermined differ-
ences in MIF expression.
Materials andMethods
Ethics statement
All experiments,maintenance and care of the mice complied with the European Convention
for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes
guidelines (CETS n° 123) and were approved by the Ethical Committee for Animal Experi-
ments (ECAE) at the Vrije Universiteit Brussel (Permit Numbers: 14-220-4 and 14-220-6).
Infection of tsetse flies with T. congolense parasites was performed in compliance with the
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regulations for bio-safety and under approval from the Environmental administration of the
Flemish government (Permit number: BM2012-6).
Parasites, mice and infections
Clonal T. congolense parasites (Tc13) were kindly provided by Dr. Henry Tabel (University of
Saskatchewan, Saskatoon) and stored at -80°C.Wild type (WT) C57Bl/6 mice were obtained
from Janvier. MIF deficient (Mif-/-) C57Bl/6 mice generated as described in [60] were bred in
our animal facility. Female mice (7–8 weeks old) were infected intraperitoneally (i.p.) with 2 x
103 Tc13 trypanosomes.Alternatively, tsetse fly infectionwas achieved by feeding teneral flies
on T. congolense-infectedmice as described in [19]. When required, infectedmice were treated
i.p. with 200 ng of mouse recombinant MIF (rMIF, Abcam, ab191658) every second day for 1
week. Parasite and red blood cell (RBC) numbers in bloodwere determined via hemocytometer
by cold tail-cut (2.5 μl blood in 500 μl RPMI). Anemia was expressed as the percentage of
reduction in RBC counts compared to non-infected animals. Packed cell volume (PCV) was
measured following collection of anti-coagulated blood in heparinized capillaries and centrifu-
gation at 9500g for 7 min. using a micro-centrifuge (Fisher BioBlock Scientific).
Fig 10. Proposedmodel for the contribution of MIF to pathogenic anemia duringT. congolense infection in trypanotolerantC57Bl/6mice. In
the chronic phase of T. congolense infection, anemia did not result from the impaired production of matureRBCs, the total amount of RBCs being similar
in infected and non-infectedmice. The infection- andMIF- induced spleen extramedullary erythropoiesis (1) could thus compensate for the impaired
differentiation of erythroblasts in the bonemarrow (2) and for the enhanced clearance of RBCs by phagocytic cells colonizing the liver and the spleen
(3). Anemia induced by T. congolensemainly occurred through hemodilution (4), that was partiallymediated by MIF. Hemodilution could also account
for thrombocytopenia and for impaired coagulation in infected mice (5). The heme catabolism following the chronically-induced erythrophagocytosis (3)
led to iron accumulation in myeloid cells (6) and to hyperbilirubinemia (7). The combination of liver injury and hemodilution resulted in declined serum
albumin levels (8) in infected mice, thereby preventing efficient removal of toxic molecules from the circulation, including bilirubin.This could cause
multiple organ failure (MOF, 9) that culminates in reduced survival of the infected host.
doi:10.1371/journal.ppat.1005862.g010
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Cell isolation protocol
Liver cell isolation was performed as describedby Stijlemans et al. [61]. Briefly, livers from
CO2 euthanizedmice were perfusedwith 30 ml heparinized saline (10 units/ml; Leo Pharma)
containing 0.05% collagenase type II (Clostridium histolyticum; Sigma-Aldrich), excised and
rinsed in saline. Following mincing in 10 ml digestive media (0.05% collagenase type II in
Hanks' Balanced Salt Solution (HBSS) without calcium or magnesium; Invitrogen) and incuba-
tion at 37°C for 30 min., the digested liver was homogenized and filtered (40 μm pore filter).
The cell suspension was centrifuged (7 min., 300×g, 4°C) and the pellet treated with erythro-
cyte-lysis buffer. Following centrifugation (7 min., 300×g, 4°C) the pellet was resuspended in
2–5 ml RPMI/5% FCSmedium, cells counted and adjusted at 107 cells/ml for flow-cytometric
analysis and cell culturing.
Spleen and bonemarrow (tibia and femur) cells were obtained by homogenizing the organs
in 10 ml RPMI/5%FCSmedium, passing the suspension through a 40 μm pore filter and centri-
fugation (7 min., 300×g, 4°C). Cells were counted and brought at 107 cells/ml in RPMI/5% FCS
medium for RBC analysis via flow cytometry. Remaining cells were pelleted (7 min., 300×g,
4°C) and subsequently treated with erythrocyte-lysisbuffer and processed as described for the
liver (see above) for analysis of white blood cells (WBCs).
Cell culturing
Cells were diluted at 2x106 cells/ml in complete medium (RPMI-1640 medium, 10% FBS, 1%
sodium pyruvate (Gibco), 1% non-essential amino acids (Gibco), 1% glutamate, 1% penicillin-
streptomycin). Next, 500 μl of cell suspension/well were cultured (36–48 hours, 37°C, 5% CO2)
in 48 well plates (Nunc) and the supernatant was tested in ELISA.
Flow cytometry
To analyze the RBC composition and platelet counts, the blood, spleen and bonemarrow cells
were analysed omitting RBC lysis. Briefly, total blood (2.5 μl diluted in 500 μl RPMI/5% FCS)
and 106 spleen or bone marrow cells (in 100 μl) were incubated (15 min., 4°C) with Fc-gamma
blocking antibody (2.4G2, BD Biosciences), and subsequently stained with labelled antibodies
(S1 Table) and matching control antibodies. Samples were washed with PBS, measured on
FACSCanto II (BD Bioscience) and results were analysed using FlowJo software by excluding
CD45+ cells and gating on Ter-119+ or CD41+ cells.
The WBC composition within the bonemarrow, spleen and liver cells and the B cell compart-
ment in the spleen (106 cells/100 μl) were analyzed after RBC lysis as describedabove using labelled
antibodies (S1 Table). The results were analysed after selectionof CD45+ cells, followed by exclu-
sion of aggregated and death cells (7AAD+, BD Pharmingen). Annexin-V staining was performed
as describedby the suppliers (TACS Annexin-V FITCApoptosis Detectionkit, R&D Systems).
Cytokine, chemokine and antibody analysis
Bloodwas collected from CO2 euthanizedmice via cardiac puncture, centrifuged (15 minutes,
10.000xg, 25°C), and serumwas kept at -20°C. Serum levels of IFN-γ, IL-6, IL-10, IL-12p70,
TNF and KC (CXCL1) were determined using the V-PLEX CustomMouse Cytokine assay
(Meso Scale Discovery, Maryland, USA). SerumMIF levels were measured by ELISA as recom-
mended by the suppliers (R&D Systems). Alternatively, culture medium concentrations of
MIF, TNF, CCL2 and KC (R&D Systems) as well as IFN-γ, IL-6 and IL-10 (Pharmingen) were
determined by ELISA as recommended by the suppliers. Parasite-specific IgG responses were
determined using soluble lysate freshly prepared from DEAE-purifiedT. congolense parasites
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recovered fromWTmice at the peak of infection (around day 7). Lysate was coated overnight
at 10 μg/ml PBS in 96-well Maxisorp plates (NUNC). Plates were washed (0.1% Tween 20 in
PBS) and blocked (1% BSA in PBS) for 1 hour. Next, plates were washed and the sera (100 μl)
serially diluted starting from 1/100 in blocking buffer were added. The ELISAwas subsequently
performed as describedby the suppliers (SBA Clonotyping system-HRP kit (SouthernBiotech,
USA)). As negative controls, blood samples incubated on lysate-free plates were used. The
OD450nm recorded on lysate-free plates was subtracted from the OD450nm recorded on lysate-
coated plates.
Real-time quantitative polymerase chain reaction (RT-QPCR) analysis
One μg of total RNA prepared from 107 cells (RNeasy plus mini kit, Qiagen) was reverse-tran-
scribed using oligo(dT) and Superscript II Reverse Transcription following the manufacturer's
recommendations (RocheMolecular Systems). RT-QPCR was performed in an iCycler iQ,
with iQ SYBR Green Supermix (Bio-Rad). Primer sequences were Vcam-1-F: 5’-CTCTCCCAG
GAATACAACGA-3’, Vcam-1-R: 5’-CACGTCAGAACAACCGAATC-3’ andMaea-F: 5’-GA
GTGGTCTCCTCTCAACAG-3’,Maea-R: 5’-AGCTACCATCTGTC TGGATG-3’. PCR cycles
consisted of 1-minute denaturation at 94°C, 45-second annealing at 55°C, and 1-minute exten-
sion at 72°C. Fold change in gene expression was expressed as compared to non-infected
animals after normalization against the Ct value of the ribosomal S12 (Mrps12) protein as
household gene.
Erythrophagocytosisassay
The pHrodo-labeling of red blood cells (RBCs) was described in [35]. 109 pHrodo-labelled
RBCs isolated from non-infectedWTmice were injected i.v. in WT orMif-/- mice. 18 h later,
mice were sacrificed, liver and spleen CD11b+Ly6CintLy6G+ PMNs, CD11b+Ly6ChighLy6G-
monocytes and CD11b+Ly6C-Ly6G-F4/80+ macrophages were tested for delta median fluores-
cent intensity (MFI) of the intracellular pHrodo signal determined by subtracting the PE signal
of cells frommice receiving unlabeled RBCs from the PE signal of cells frommice receiving
pHrodo-labeled RBCs.
Aspartate transaminase (AST) and alanine transaminase (ALT)
measurement
SerumAST and ALT levels were determined as described by the suppliers (BoehringerMann-
heim Diagnostics).
Hemodilution assay
100 μl of APC-labelled hydroxyethyl starch (APC-HES (130/0.4) at 100 μg/ml in 0.9% NaCl)
was injected i.v. (as described in [62]). After 5–10 min., bloodwas collected and the APC signal
measured via cytofluorimeter (OD660nm, Ultra Microplate reader, ELx808, Bio-Tek instru-
ments.inc). A standard curve consisting of a serial dilution of APC-HES (starting from 200 μg/
ml) diluted in blood from non-infectedmice was used to calculate the concentration of
APC-HES in collected blood. The OD660nm from blood of non-infectedmice was subtracted
from all samples.
Measurement of serumhemoglobin, iron, bilirubin and albumin content
For hemoglobin quantification, 2 μl of blood collected via cold tail cut was diluted in 200 μl dis-
tilled water in a 96 well round bottom plate (Falcon). After incubation for 30 min. at 37°C and
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centrifugation (600xg, 10 min.), the supernatant was collected and the OD550nm measured. The
hemoglobin concentration was calculated using a standard (Sigma) curve. Total iron (IRON
FZ kit, Chema Diagnostics), bilirubin and albumin (Chema Diagnostica, Italy and Sigma
Aldrich, respectively) were measured as recommended by the suppliers.
Bleeding time
Bleeding times of mice were obtained by using the tail-cut model [63]. Briefly, anesthetized ani-
mals were transected at the 5-mmmark from the tip of the tail and incubated in warm saline
(37°C). The time for cessation of bleeding was recorded. The experiment was terminated after
15 min. to avoid lethality, whereby the tail was cauterized and the bleeding time was taken as
15 min.
Pearls Staining (PrussianBlue)
Total spleens and the largest lobe of the liver were embedded in Tissue-Tek O.C.T. compound
(Sakura BelgiumB.V.B.A.) and kept at -80°C. Next, 5 μm cryosectionswere cut using a Leica
microtome, fixed in cold acetone for 15 min. and washed shortly in distilledwater (2–3
changes). The sections were stained for 20 min. in equal volumes of warmHCl 4% and K4[Fe
(CN)6]3H2O 4% at 45°C. After washing shortly 3x with distilledwater, the slides were coun-
terstained with NFR (Nuclear Fast Red, Sigma-Aldrich) for 5 min. After rinsing 3x with dis-
tilled water, the slides were dehydrated (short in EtOH 96%, short in EtOH 100% (2x), 3 min.
in xylol (2x)) and mounted with DPXmounting medium (Sigma-Aldrich). Images were
obtained using an OLYMPUS BX41 fluorescent microscope. The CellSensDimension 1.9 soft-
ware was used for quantification. For each sample, an average quantification of 5 representative
images was determined. The results are expressed as % stained area within the region of
interest.
Statistical analysis
The GraphPad Prism software was used for statistical analyses (Two-way ANOVA or student
t-test). Values are expressed as mean ± SEM. Values of p 0.05 are considered significant.
Supporting Information
S1 Table. Fluorescently labeled antibodies used.
(DOCX)
S1 Fig. MIF serum levels during the course of T. congolense infection.MIF serum levels dur-
ing the course of T. congolense infection in C57Bl/6 mice. Results are representative of 3 inde-
pendent experiments and presented as mean of 6 individual mice ± SEM, : p0.05, :
p0.01, : p0.001.
(TIF)
S2 Fig. MIF deficiencyconfers partial protection against a tsetse fly-basedT. congolense
infection. (A) Parasitemia, (B) survival time and (C) anemia during the course of infection in
C57Bl/6 mice.Wild type (WT, black symbol);Mif-/- (white symbol) mice. Results are represen-
tative of 2 independent experiments and presented as mean (A, C) or median (B) of 6 individ-
ual mice ± SEM, : p0.01.
(TIF)
S3 Fig. MIF deficiencyreduces hepatosplenomegalyduring T. congolense infection.Repre-
sentative picture of livers and spleens from T. congolense-infected (3 months p.i.) WT and
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Mif-/- mice. There was no difference in liver and spleen size between non-infectedWT and
Mif-/- mice.
(TIF)
S4 Fig. MIF negatively affects anti-trypanosomeIgG responses during T. congolense infec-
tion.At 1.5, 3 and 4 months p.i., the serum IgG antibody titers fromWT (black box) andMif-/-
(white box) mice were determined by ELISA on lysates from T. congolense parasites. The
serumwas ½ serially diluted starting from a 1/100 dilution and the OD450nm (subtracting back-
ground OD450nm of lysate-free ELISA) was plotted. In parallel, the anti-trypanosome IgG level
of non-infectedmice also was determined. Results are representative of 2 independent experi-
ments and presented as median of 3–4 individual mice ± SEM.
(TIF)
S5 Fig. Representative gating strategy used to identify B-cells, apoptotic B-cells and germi-
nal center B-cells.At 3 months p.i., (A) representative gating strategy used to identify splenic
mature B-cells: CD45+ cells and singlet cells were gated followed by selection of B220+MHC-
II+ B-cells. The percentage of Annexin-V+ B-cells is shown in histogram for non-infected
(black line) and infected (blue line)WT andMif-/- mice. (B)Within the splenic B220+MHC-
II+ cells, the germinal center GL-7+Fas+ B-cells were identified in non-infected (left panel), WT
(middle panel) andMif-/- (right panel) mice.
(TIF)
S6 Fig. Representative gating strategy used to discriminatemature and immature RBCs,
and the different stages of erythroiddevelopment.At 3 months p.i., (A) representative gating
strategy used to identifymature RBCs (erythrocytes,Ery.) and immature RBCs (reticulocytes,
Ret.) in bonemarrow. Within CD45- cells gated from a FSC-A/SSC-A plot, Ter-119+ cells were
selected and displayed in a histogram. CD71 expression was then used to discriminatemature
RBCs (erythrocytes (Ery.), Ter-119+ CD71-) and immature (reticulocytes (Ret.), Ter-119+
CD71+) RBCs. (B) 7AAD-CD45-Ter-119+ cells were plotted in a CD44/FSC-A plot to identify
nucleated erythroblasts (pro (I), basophilic (II), polychromatic (III, orthochromatic (IV) eryth-
roblasts), from nucleated reticulocytes (V) and enucleated erythrocytes (VI). (C) Representa-
tive percentage of the different erythroid populations in the bone marrow (upper panels) and
spleen (lower panels) of non-infected (naive, left panel), infectedWT (middle panel) and
infectedMif-/- (right panel) mice.
(TIF)
S7 Fig. Representative gating strategy used to discriminate PMNs, Ly6Chigh monocytes,
macrophages and platelets.At 3 months p.i., (A) following gating on 7AAD- cells, CD45+
cells were displayed in a CD11b/CD31 plot to out-gate endothelial cells. A Ly6C/Ly6G plot
allowed to distinguish within the CD11b+ population Ly6ChighLy6G- inflammatorymonocytes
and CD11b+Ly6CintLy6G+ neutrophils (PMNs). The CD11b+Ly6Cint/-Ly6G- population was
tested for F4/80 expression to definemacrophages. (B) For platelet identification, small cells
were selected in a SSC-A/FSC-A plot and then analyzed in a CD41/CD11b plot to identify
CD41+ platelets.
(TIF)
S8 Fig. Blood and plasma volumes during T. b. brucei infection.At 1 month p.i., WT (black
bar) orMif-/- (open bar) mice were exsanguinated via cardiac puncture and tested for (A) the
total blood volume collected and (B) Pack cell volume (PCV). (C) Total plasma (white bars)
and PCV (black bars) volumes are calculated based on the total blood (A) and the % PCV (B).
Non-infectedmice (N), infectedmice (I). Results are representative of 2 independent
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experiments and presented as mean of 5 individual mice ± SEM, : p0.01, : p0.001.
(TIF)
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